591 related articles for article (PubMed ID: 27058662)
1. Microbiome and Anticancer Immunosurveillance.
Zitvogel L; Ayyoub M; Routy B; Kroemer G
Cell; 2016 Apr; 165(2):276-87. PubMed ID: 27058662
[TBL] [Abstract][Full Text] [Related]
2. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.
Gopalakrishnan V; Helmink BA; Spencer CN; Reuben A; Wargo JA
Cancer Cell; 2018 Apr; 33(4):570-580. PubMed ID: 29634945
[TBL] [Abstract][Full Text] [Related]
3. The Human Microbiome and Cancer.
Rajagopala SV; Vashee S; Oldfield LM; Suzuki Y; Venter JC; Telenti A; Nelson KE
Cancer Prev Res (Phila); 2017 Apr; 10(4):226-234. PubMed ID: 28096237
[TBL] [Abstract][Full Text] [Related]
4. Autophagy in natural and therapy-driven anticancer immunosurveillance.
Pietrocola F; Bravo-San Pedro JM; Galluzzi L; Kroemer G
Autophagy; 2017; 13(12):2163-2170. PubMed ID: 28598229
[TBL] [Abstract][Full Text] [Related]
5. Immune System Efficiency in Cancer and the Microbiota Influence.
Barbosa AM; Gomes-Gonçalves A; Castro AG; Torrado E
Pathobiology; 2021; 88(2):170-186. PubMed ID: 33588418
[TBL] [Abstract][Full Text] [Related]
6. Could the menagerie of the gut microbiome really cure cancer? Hope or hype.
Abid MB
J Immunother Cancer; 2019 Apr; 7(1):92. PubMed ID: 30940203
[TBL] [Abstract][Full Text] [Related]
7. The microbiome in anti-cancer therapy.
Bashiardes S; Tuganbaev T; Federici S; Elinav E
Semin Immunol; 2017 Aug; 32():74-81. PubMed ID: 28431920
[TBL] [Abstract][Full Text] [Related]
8. [The role of intestinal microbiota in the response to anti-tumor therapies].
Vétizou M; Daillère R; Zitvogel L
Med Sci (Paris); 2016 Nov; 32(11):974-982. PubMed ID: 28008838
[TBL] [Abstract][Full Text] [Related]
9. Receptors that interact with nectin and nectin-like proteins in the immunosurveillance and immunotherapy of cancer.
Chan CJ; Andrews DM; Smyth MJ
Curr Opin Immunol; 2012 Apr; 24(2):246-51. PubMed ID: 22285893
[TBL] [Abstract][Full Text] [Related]
10. Revisiting the hygiene hypothesis for allergy and asthma.
Liu AH
J Allergy Clin Immunol; 2015 Oct; 136(4):860-5. PubMed ID: 26449798
[TBL] [Abstract][Full Text] [Related]
11. Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment.
Vasaturo A; Verdoes M; de Vries J; Torensma R; Figdor CG
Immunobiology; 2015 Feb; 220(2):243-8. PubMed ID: 25466585
[TBL] [Abstract][Full Text] [Related]
12. From cancer immunosurveillance to cancer immunotherapy.
Stagg J; Johnstone RW; Smyth MJ
Immunol Rev; 2007 Dec; 220():82-101. PubMed ID: 17979841
[TBL] [Abstract][Full Text] [Related]
13. A fresh look at tumor immunosurveillance and immunotherapy.
Smyth MJ; Godfrey DI; Trapani JA
Nat Immunol; 2001 Apr; 2(4):293-9. PubMed ID: 11276199
[TBL] [Abstract][Full Text] [Related]
14. Cyclin B1 and other cyclins as tumor antigens in immunosurveillance and immunotherapy of cancer.
Egloff AM; Vella LA; Finn OJ
Cancer Res; 2006 Jan; 66(1):6-9. PubMed ID: 16397206
[TBL] [Abstract][Full Text] [Related]
15. Host-microbe cross talk in cancer therapy.
Vanhoecke B; Stringer A
Curr Opin Support Palliat Care; 2015 Jun; 9(2):174-81. PubMed ID: 25872117
[TBL] [Abstract][Full Text] [Related]
16. Modulation of immunosurveillance by tumor-intrinsic genomic alterations.
Furman C; Zhu P; Korpal M
Immunotherapy; 2017 Dec; 9(16):1305-1307. PubMed ID: 29185394
[No Abstract] [Full Text] [Related]
17. Immunosurveillance and immunoediting--can the immune response be made more "immunodemocratic"?
Mincheff M
J BUON; 2009 Sep; 14 Suppl 1():S89-96. PubMed ID: 19785075
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance.
Zitvogel L; Galluzzi L; Smyth MJ; Kroemer G
Immunity; 2013 Jul; 39(1):74-88. PubMed ID: 23890065
[TBL] [Abstract][Full Text] [Related]
19. Interferons, immunity and cancer immunoediting.
Dunn GP; Koebel CM; Schreiber RD
Nat Rev Immunol; 2006 Nov; 6(11):836-48. PubMed ID: 17063185
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactivity between microbial and tumor antigens.
Zitvogel L; Kroemer G
Curr Opin Immunol; 2022 Apr; 75():102171. PubMed ID: 35219942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
